• 2019.06.30
    ¬P´Á¤é

¼Æ½XÀøªk§Uªv¾~¤ùÃþÃĪ«¤WÅ}
¥þ¤Ñ­Ô°lÂܯfúG «Ý½T»{¼Ð·Ç

[2019.06.30] µoªí

¬ü°ê¾~¤ùÃþÃĪ«­P©R­Ó®×ªñ¦~«æ¼W¡A¦¨­¢¤Á¦M¾÷¡C¦³¬ì§Þ¤½¥q»PÃļt¦X§@¶}µo´¼¯à¨t²Î¡A³z¹L§ïÅܱwªÌ¦æ¬°þӤⱱ¨î¥ÎÃÄ¡AÁקK¤WÅ}¡A³Qµø¬°¡u¼Æ½XÀøªk¡v(digital therapeutics)µo®i¼ç¤Oªº¹êÃÒ¡C±M®aºÙ¼Æ½XÀøªk¦³§U°lÂܯf¤H±¡úG¡AµS¦p¥þ¤Ñ­Ôªº¼Æ½XÂå¥Í¡A¦ý¦³±M®a»{¬°¦¹ÃþªvÀø¤´¦³«Ý½T»{¼Ð·Ç¡A¤~¥iÅýÂå±w§¡¥i¦w¤ß¨Ï¥Î¡C©ú³ø°OªÌ¡@ùºÍµX

±M¬ã¼Æ½XÀøªk§Þ³Nªº¬ì§Þ¥ø·~Pear Therapeutics(PT)¤µ¦~1¤ë»P·ç¤h¿ÕµØ»sÃÄ(Novartis)ºX¤Uªº¤s¼w¤h(Sandoz)Ãļt¦X§@¡A±À¥X¼Æ½XÀøªk²£«~reSET-O¡A¨ÃÀò¬ü°ê­¹«~¤ÎÃĪ«ºÞ²z§½(FDA)§å­ã¥Î©ó¹ïªv¾~¤ùÃþÃĪ«¦¨Å}¡CreSET-O°ò¥»¤W¬O¤@­ÓªvÀøºÞ²z¹q¸£µ{¦¡¡A¥i´£¨Ñ¬°´Á12©Pªº»{ª¾¦æ¬°ªvÀø¡A¶·°t¦X§ÙÅ}ÃĪ«¤B¤þ¿Õ°Ø(buprenorphine)¡A¦bÂå¥ÍºÊ¹î¤U¨Ï¥Î¡C¯f¤H¶·®Ú¾ÚreSET-Oªº«ü¥Ü¦^µª°ÝÃD¡A¥]¬A¦^³ø¥ÎÃĪ¬úG¡B§ÙÂ_¤ÏÀ³µ¥¸ê®Æ¡AÂåÀø¹Î¶¤³z¹L°O¿ýºÊ¹î¯f¤Hªº§ÙÅ}¶i«×¡Aµ¹¤©¾A·í´£¿ô¤Î°V½m«ü¥Ü¡A³Ì²×¥Ø¼Ð¬°¡u­«³]¡v¦]ÃĪ«¤WÅ}¦Ó¾D§á¦±ªº¸£³¡ªº¤ÏõX¨t²Î¡A¥O¯f¤H¤£¦A¹L«×¨Ì¿àÃĪ«¡C

¡u³U¤¤Âå¥Í¡vµ¹¤©°V½m«ü¥Ü

³o´Ú¼Æ½XÀøªk²£«~¦¨®Ä¬Û·í¨ô¶V¡AÁ{þH´ú¸ÕÅã¥Ü¡A°t¦X¶Ç²Î§ÙÅ}ªvÀø¨Ï¥Îªº²Ä¤@¥NreSET¦b´ú¸Õ3­Ó¤ë«á¥O40%¯f¤H§Ù°£°sºë¡B¥i¥d¦]¡B¤j³Â¤Î¨ä¥L¦¨Å}ª«½è¡A¦Ó¥u±µ¨ü¶Ç²ÎªvÀøªº¯f¤H¥u¦³17.6%¦¨¥\§ÙÅ}¡C¦Ü©óreSET-O«h¦b´ú¸Õªº12©P¤º¥O82.4%¯f¤H°í«ùªvÀø¡A¦ý¥u±µ¨ü¶Ç²ÎªvÀøªº¯f¤H¥u¦³68.4%Ä~ÄòªvÀø¡C

PTÁ{þH¤Î³WºÞ¤p²Õ­t³d¤H°¨¨½¦è©_(Yuri Maricich)¦Vªk·sªÀºÙ¡A¼Æ½XÀøªk¬O§Q¥Î³n¥óªv¯fªº»{¥i¬ì¾ÇÀøªk¡A¯à¥[±jÂå±w±µÄ²¡A´£¨Ñ§Y®É¶EÂ_¡A¾A¦X¬°ÃĪ«¦¨Å}¡B§íÆ{¯gµ¥¯e¯fªº±wªÌ¬I¤©±K¤Áªº¦æ¬°ªvÀø¡C¦o±j½Õ¡A¼Æ½XÀøªk²£«~ªº³]­p©M¥Í²£¹Lµ{ÄYÂÔ¡A¦bÀø®Ä»P¦w¥þ©Ê¤W¡A»P¤@¯ëÃĪ«µL²§¡C¬ü°ê¹F¯S­T´µ¾Ç°|¬ì§Þ»P¦æ¬°°·±d¤¤¤ß´¿»PPT¤Î¨ä¥L¶}µo¼Æ½XÀøªkªº¼t°Ó¦X§@®i¶}ÀøªkÁ{þH¸ÕÅç¡C¤¤¤ßÁ`ºÊ°¨§Æ(Lisa Marsch)»¡¡A¦³Ãö¬ã¨s¤w«ùÄò¼Æ¤Q¸ü¡A¦ýª½¦Ü´¼¯à¹q¸Ü´¶¤Î¡A²×¥OÀøªk¦¨¯u¡A¡u¤H­Ì¥i¥H±N¤â¾÷·í§@24¤p®É¥þ¤Ñ­Ô«Ý©Rªº³U¤¤Á{þHÂå¥Í¡v¡C

±M®a½èºÃÄÝ´¶³q¼Æ½X¤u¨ã

¼Æ½XÀøªkªº«e´º¤éº¥¨üª`¥Ø¡C¥«³õ½Õ¬d¾÷ºcCB Insight«ü¥X¡A¼Æ½XÀøªk®i¥ÜºÞ²z¿}§¿¯fµ¥ªø´Á¯e¯fªº¥þ·s¤è¦¡¡A¤Þ°_Ãļt·¥¤j¿³½ì¡A¥h¦~¼Æ½XÀøªk³Ð¬ì¤½¥qªº§ë¸êÃB­¿¼W¦Ü8.11»õ¬ü¤¸¡C¥t¤@¥«³õ½Õ¬d¾÷ºcJuniper§ó¹w´Á2024¦~¼Æ½XÀøªkªº¥«³õ³W¼Ò±N¹F¨ì320»õ¬ü¤¸¡C

¤£¹L¡A¥ç¦³±M®a¹ï¼Æ½XÀøªk¬O§_ÄÝ©ó¡uÀøªk¡v¦³«O¯d¡C¬ü°êÂåÀø¨ó·|¦æ¬FÁ`µô°¨¹F©Ô(James Madara)2016¦~«K´¿Äµ§i¼Æ½XÀøªk¥u¬OµL¿×ªº¦W¥Ø¡A»P¤@¯ë­p¨B¾¹¤§Ãþªº¼Æ½X°·±d¤u¨ã¨S¦³°Ï§O¡C

¬ü°êÃĪ««~½èºÞ±±Åv«Â¡m¬ü°êÃĨå¡n©e­û·|¦¨­û§Qºû(Michael Levy)«ü¥X¡A­n±À°Ê¼Æ½XÀøªk¡A°£¤F­q¥ßªk³W½T«O¨äÀø®Ä»P¦w¥þ¡A¥ç¦³¥²­n¦p´¶³qÃĪ«¯ë«Ø¥ß«~½è¼Ð·Ç¡A§_«h¬ÛÃöµ{¦¡¥i¯à³Q¤£ªkªÌ§ïÀY´«­±¡A¼vÅTÀø®Ä¡AÃø¥OÂå±w¦³«H¤ß¡C

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2019 mingpaocanada.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Vancouver Chinese Newspaper

5368 Parkwood Place, Richmond B.C. V6V 2N1 | Tel.: (604) 231-8998 | Fax: (604) 231-9881/9884 | Advertising Hotline Tel.: (604) 231-8992